Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

ProTreatment ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6%   Bankruptcy risk   1.1% 1.2% 5.6% 3.5% 1.4% 1.7% 10.0% 10.0%   Credit score (0-100)   85 83 41 52 77 72 25 25   Credit rating   A A BBB BBB A A BB BB   Credit limit (kDKK)   82.6 60.9 0.0 0.0 25.7 6.4 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,830 3,455 3,988 5,515 7,830 8,289 0.0 0.0   EBITDA   767 1,007 -586 210 2,045 1,334 0.0 0.0   EBIT   746 978 -611 188 2,021 1,312 0.0 0.0   Pre-tax profit (PTP)   770.2 996.8 -599.3 156.4 2,038.1 1,115.2 0.0 0.0   Net earnings   591.4 765.7 -489.0 118.5 1,575.7 867.0 0.0 0.0   Pre-tax profit without non-rec. items   770 997 -599 156 2,038 1,115 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   107 77.9 52.7 30.3 41.1 99.1 0.0 0.0   Shareholders equity total   1,528 1,704 465 584 2,159 3,026 1,496 1,496   Interest-bearing liabilities   876 1,407 1,828 2,813 2,530 8,003 0.0 0.0   Balance sheet total (assets)   3,493 4,010 3,799 4,595 6,308 12,434 1,496 1,496   Net Debt   872 1,402 1,707 2,505 2,501 7,991 -1,496 -1,496     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,830 3,455 3,988 5,515 7,830 8,289 0.0 0.0   Gross profit growth   30.9% 22.1% 15.4% 38.3% 42.0% 5.9% -100.0% 0.0%   Employees   4 5 7 9 9 11 0 0   Employee growth %   0.0% 25.0% 40.0% 28.6% 0.0% 22.2% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,493 4,010 3,799 4,595 6,308 12,434 1,496 1,496   Balance sheet change%   27.9% 14.8% -5.3% 21.0% 37.3% 97.1% -88.0% 0.0%   Added value   767.2 1,006.7 -585.7 209.9 2,043.7 1,333.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   54 -58 -51 661 616 503 -1,901 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 -1.0 1.0 2.0 3.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   26.4% 28.3% -15.3% 3.4% 25.8% 15.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   25.3% 27.1% -14.9% 4.5% 37.7% 14.2% 0.0% 0.0%   ROI %   37.2% 36.6% -20.8% 6.3% 50.0% 17.0% 0.0% 0.0%   ROE %   48.0% 47.4% -45.1% 22.6% 114.9% 33.4% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   43.8% 42.5% 12.2% 12.7% 34.2% 24.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   113.7% 139.3% -291.5% 1,193.4% 122.3% 599.2% 0.0% 0.0%   Gearing %   57.3% 82.5% 393.0% 482.1% 117.2% 264.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1.8% 1.8% 1.1% 1.3% 0.7% 4.1% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.7 1.7 1.1 1.0 1.2 1.7 0.0 0.0   Current Ratio   1.7 1.7 1.1 1.0 1.2 1.7 0.0 0.0   Cash and cash equivalent   3.6 4.6 120.7 307.9 28.8 11.8 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,322.7 1,566.2 454.6 -107.8 885.1 4,258.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   192 201 -84 23 227 121 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   192 201 -84 23 227 121 0 0   EBIT / employee   187 196 -87 21 225 119 0 0   Net earnings / employee   148 153 -70 13 175 79 0 0